Christopher H. Crane
Impact in
- Oncology top 0.05%
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 209
- Pancreatic and Hepatic Oncology Research 123
- Colorectal Cancer Surgical Treatments 67
- Hepatology 46
- Hepatocellular Carcinoma Treatment and Prognosis 45
- Co-authors
- Robert A. Wolff (82 shared papers)Peter W. T. Pisters (48 shared papers)Douglas B. Evans (43 shared papers)Jeffrey E. Lee (31 shared papers)Prajnan Das (88 shared papers)James L. Abbruzzese (34 shared papers)Jean‐Nicolas Vauthey (39 shared papers)Gauri Rajani Varadhachary (32 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (85 papers)Journal of Clinical Oncology (27 papers)Annals of Surgical Oncology (26 papers)Cancer (21 papers)Practical Radiation Oncology (11 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Christopher H. Crane
382 papers receiving 23.6k citations
Christopher H. Crane's Hit Papers
Peers
Comparison fields: 5 of 133
- Oncology 15.3k
- Cancer Research 2.6k
- Pulmonary and Respiratory Medicine 5.6k
- Surgery 6.7k
- Hepatology 1.2k
Countries citing papers authored by Christopher H. Crane
This map shows the geographic impact of Christopher H. Crane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher H. Crane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher H. Crane more than expected).
Fields of papers citing papers by Christopher H. Crane
This network shows the impact of papers produced by Christopher H. Crane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher H. Crane. The network helps show where Christopher H. Crane may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher H. Crane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 401 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer Hit paper breakdown → | 2022 | 1083 |
| 2 | Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy Hit paper breakdown → | 2006 | 715 |
| 3 | Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial Hit paper breakdown → | 2011 | 683 |
| 4 | Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease Hit paper breakdown → | 2008 | 668 |
| 5 | Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head Hit paper breakdown → | 2008 | 604 |
| 6 | 2007 | 484 | |
| 7 | Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer Hit paper breakdown → | 2018 | 477 |
| 8 | 2004 | 468 | |
| 9 | 2012 | 438 | |
| 10 | Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy Hit paper breakdown → | 2019 | 429 |
| 11 | 2012 | 415 | |
| 12 | 2009 | 409 | |
| 13 | 2008 | 394 | |
| 14 | Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications Hit paper breakdown → | 2014 | 381 |
| 15 | Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Hit paper breakdown → | 2015 | 360 |
| 16 | Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline Hit paper breakdown → | 2019 | 336 |
| 17 | 2006 | 312 | |
| 18 | Hilar Cholangiocarcinoma: expert consensus statement Hit paper breakdown → | 2015 | 304 |
| 19 | 2016 | 291 | |
| 20 | 2007 | 284 |
About Christopher H. Crane
Christopher H. Crane is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Surgery and Radiation, having authored 401 papers that have together received 24.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (123 papers), Colorectal Cancer Surgical Treatments (67 papers), Colorectal and Anal Carcinomas (66 papers), Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Gastric Cancer Management and Outcomes (43 papers), Advanced Radiotherapy Techniques (35 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers) and Cancer Genomics and Diagnostics (22 papers). The work is most often cited by research in Oncology (15.3k citations), Cancer Research (2.6k citations), Pulmonary and Respiratory Medicine (5.6k citations), Surgery (6.7k citations) and Hepatology (1.2k citations). Christopher H. Crane has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Robert A. Wolff, Peter W. T. Pisters, Douglas B. Evans, Jeffrey E. Lee, Prajnan Das, James L. Abbruzzese, Jean‐Nicolas Vauthey, Gauri Rajani Varadhachary, Nora Anita Janjan and Huamin Wang. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Annals of Surgical Oncology, Cancer and Practical Radiation Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.